HTV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell―mediated killingRICHARD, Jonathan; SINDHU, Sardar; PHAM, Tram N. Q et al.Blood. 2010, Vol 115, Num 7, pp 1354-1363, issn 0006-4971, 10 p.Article

NKG2D receptor regulates human effector T-cell cytokine productionBARBER, Amorette; SENTMAN, Charles L.Blood. 2011, Vol 117, Num 24, pp 6571-6581, issn 0006-4971, 11 p.Article

Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome InhibitorsVALES-GOMEZ, Mar; CHISHOLM, Susan E; CASSADY-CAIN, Robin L et al.Cancer research (Baltimore). 2008, Vol 68, Num 5, pp 1546-1554, issn 0008-5472, 9 p.Article

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsSTAMOVA, S; CARTELLIERI, M; RIEBER, E. P et al.Leukemia. 2011, Vol 25, Num 6, pp 1053-1056, issn 0887-6924, 4 p.Article

TNK cells (NKG2D⁺ CD8⁺ or CD4⁺ T lymphocytes) in the control of human tumorsMACCALLI, Cristina; SCARAMUZZA, Samantha; PARMIANI, Giorgio et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 5, pp 801-808, issn 0340-7004, 8 p.Article

Induction of NKG2D Ligands and Subsequent Enhancement of NK Cell-mediated Lysis of Cancer Cells by Arsenic TrioxideKIM, Joo-Young; BAE, Jae-Ho; LEE, Sang-Hwa et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 5, pp 475-486, issn 1524-9557, 12 p.Article

TNFα stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cellsGUILLOTON, F; DE THONEL, A; JEAN, C et al.Leukemia. 2005, Vol 19, Num 12, pp 2206-2214, issn 0887-6924, 9 p.Article

Soluble MICA in malignant diseasesHOLDENRIEDER, Stefan; STIEBER, Petra; PETERFI, Andrea et al.International journal of cancer. 2006, Vol 118, Num 3, pp 684-687, issn 0020-7136, 4 p.Article

RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in LymphomaLAM, Adeline R; LE BERT, Nina; RAULET, David H et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 8, pp 2193-2203, issn 0008-5472, 11 p.Article

NKG2D and its ligands: active factors in the outcome of solid organ transplantation?SUAREZ-ALVAREZ, Beatriz; FERNANDEZ-SANEHEZ, Alba; LOPEZ-VAZQUEZ, Antonio et al.Kidney international supplements (Print). 2011, Vol 1, Num 2, pp 52-57, issn 2157-1724, 6 p.Conference Paper

Effect of NKG2D ligand expression on host immune responsesCHAMPSAUR, Marine; LANIER, Lewis L.Immunological reviews. 2010, Vol 235, pp 267-285, issn 0105-2896, 19 p.Article

Soluble MICB in malignant diseases : analysis of diagnostic significance and correlation with soluble MICAHOLDENRIEDER, Stefan; STIEBER, Petra; PETERFI, Andrea et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 12, pp 1584-1589, issn 0340-7004, 6 p.Article

Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicityMIN, D; LV, X-B; WANG, X et al.British journal of cancer. 2013, Vol 109, Num 3, pp 723-730, issn 0007-0920, 8 p.Article

Changes in natural killer cell subsets in pediatric liver transplant recipientsPHAM, Betty; PIARD-RUSTER, Karine; SILVA, Richard et al.Pediatric transplantation. 2012, Vol 16, Num 2, pp 176-182, issn 1397-3142, 7 p.Article

Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functionsLUIS ESPINOZA, J; TAKAMI, Akiyoshi; YOSHIOKA, Katsuji et al.Haematologica (Roma). 2012, Vol 97, Num 9, pp 1295-1303, issn 0390-6078, 9 p.Article

Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunctionCAROLINE ANDRE, Maya; SIGURDARDOTTIR, Dagmar; KUTTRUFF, Sabrina et al.International journal of cancer (Print). 2012, Vol 131, Num 7, pp 1601-1610, issn 0020-7136, 10 p.Article

Potential Role of NKG2D and Its Ligands in Organ Transplantation : New Target for ImmunointerventionSUAREZ-ALVAREZ, B; LOPEZ-VAZQUEZ, A; BALTAR, J. M et al.American journal of transplantation (Print). 2009, Vol 9, Num 2, pp 251-257, issn 1600-6135, 7 p.Article

Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of CancerBAOCHENG HUANG; SIKORSKI, Rachel; SAMPATH, Padma et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 3, pp 289-296, issn 1524-9557, 8 p.Article

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cellsKATOL, N; TANAKA, J; IMAMURA, M et al.Leukemia. 2007, Vol 21, Num 10, pp 2103-2108, issn 0887-6924, 6 p.Article

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNyARINA, Ainhoa; MURILLO, Oihana; SAROBE, Pablo et al.International journal of cancer. 2007, Vol 121, Num 6, pp 1282-1295, issn 0020-7136, 14 p.Article

Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA^*008 That Is Shed by Tumor Cells in ExosomesASHIRU, Omodele; BOUTET, Philippe; FERNANDEZ-MESSINA, Lola et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 481-489, issn 0008-5472, 9 p.Article

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5927-5933, issn 0008-5472, 7 p.Article

Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor ReactivityKOPP, Hans-Georg; PLACKE, Theresa; SALIH, Helmut Rainer et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7775-7783, issn 0008-5472, 9 p.Article

Chimeric NKG2D-Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic PathwaysTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2007, Vol 67, Num 22, pp 11029-11036, issn 0008-5472, 8 p.Article

Imbalance of NKG2D and its inhibitory counterparts : How does tumor escape from innate immunity?CAI ZHANG; JIAN ZHANG; HAIMING WEI et al.International immunopharmacology. 2005, Vol 5, Num 7-8, pp 1099-1111, issn 1567-5769, 13 p.Article